ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

BioLumic Expands Light-Activated Seed Trait Platform to South America

By: Newsfile

Champaign, Illinois--(Newsfile Corp. - December 8, 2025) - BioLumic, the only agricultural biotechnology company that programs heritable seed traits using light, today announced steps to expand its Corn xTraits Licensing Program into South America. This includes early-stage evaluations with GDM and a collaboration with Tropical Melhoramento & Genética (TMG), two of Brazil's leading seed companies, along with regional seed production and nursery engagement with Gro Alliance. The move builds on strong partnership and commercial momentum of xTraits in the United States, and follows BioLumic's plan to create xTraits hubs in grain-producing regions worldwide.

To view the full announcement, including downloadable images, bios, and more, click here.

Key Takeaways:

  • South America Expansion: BioLumic is extending its CornxTraits Licensing Program into South America through early-stage evaluationswith GDM, a collaboration with Tropical Melhoramento & GenĂ©tica(TMG), and seedproduction activities with Gro Alliance, building on strong U.S. momentum.
  • Regional Testing & Validation: GDM, TMG, and major grower GrupoScheffer will conduct multi-location field evaluations to assess how BioLumic'slight-activated seed traits perform within local genetics and growingconditions, creating a direct pathway to validate xTraits for farmers.
  • Path to Commercialization: Year-round nursery work in Chile andupcoming field trials in Brazil (2026-2027) will inform commercial launchplans, with broader Latin America rollout expected within 12-15 months andfuture expansion into soybean and ryegrass.

Cannot view this image? Visit: https://images.newsfilecorp.com/files/7294/277263_figure1_550.jpg

Click image above to view full announcement.


About BioLumic

Founded in 2013, BioLumic is a U.S.- and New Zealand-based agricultural biotechnology company using light signaling as a programming language for plants. Its patented xTraits technology unlocks non-GMO genetic expression traits to enhance yield, composition, and crop resilience through a one-time, light-based seed application. BioLumic traits are scalable, fast to develop, and easily integrated into existing seed systems. Learn more at www.biolumic.com or contact info@biolumic.com.

Contacts:

Sara Winters, AgTech PR for BioLumic
sara@agtechpr.com

Source: BioLumic

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/277263

Recent Quotes

View More
Symbol Price Change (%)
AMZN  226.76
+5.49 (2.48%)
AAPL  272.19
+0.35 (0.13%)
AMD  201.06
+2.95 (1.49%)
BAC  54.26
-0.29 (-0.53%)
GOOG  303.75
+5.69 (1.91%)
META  664.45
+14.95 (2.30%)
MSFT  483.98
+7.86 (1.65%)
NVDA  174.14
+3.20 (1.87%)
ORCL  180.03
+1.57 (0.88%)
TSLA  483.37
+16.11 (3.45%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.